The Partnership's Scientific Executive Committee engages a premier group of doctors and researchers in developing a common agenda for research progress in lung cancer. We are grateful to these world-renowned individuals for giving their time to help ensure the Partnership's programs are of the highest quality, are based in scientific evidence, and are of the greatest benefit to the lung cancer patients of today, tomorrow and beyond.

	Chair Pasi A. Jänne, MD, PhD, MSc Harvard Medical School Dana-Farber Cancer Institute
	Vice-Chair Jill M. Siegfried, PhD University of Pittsburgh Hillman Cancer Center
	Kathy S. Albain, MD, FACP Cardinal Bernardin Cancer Center Loyola University Chicago
	Andrea A. Bezjak, MDCM, MSc, FRCPC University of Toronto and Princess Margaret Hospital, Canada
	Julie R. Brahmer, MD, MSc The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
	Jessica S. Donington, MD NYU School of Medicine
	Carolyn M. Dresler, MD, MPA Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences
	Enriqueta Felip, MD Vall D'Hebron University Hospital Barcelona, Spain
	James R. Jett, MD National Jewish Health
	John D. Minna, MD University of Texas-Southwestern Medical Center
	Silvia Novello, MD, PhD University of Turin, San Luigi Orbassano, Italy
	Suresh S. Ramalingam, MD Emory University Winship Cancer Instituite
	Ann G. Schwartz, PhD, MPH Karmanos Cancer Institute Wayne State University
	David R. Spigel, MD Sarah Cannon Research Institute Tennessee Oncology
	Everett E. Vokes, MD University of Chicago Medical Center
	Heather A. Wakelee, MD Stanford University
	Antoinette J. Wozniak, MD Karmanos Cancer Institute Wayne State University
	Ignacio I. Wistuba, MD The University of Texas MD Anderson Cancer Center